ABOUT THERMO FISHER SCIENTIFIC
Thermo Fisher is a leading global provider of bioprocessing solutions. We simplify the development path and accelerate our customers’ innovations to bring therapies to patients, faster. With our comprehensive portfolio of products and services we are a dedicated partner throughout the biological drug development journey.
Key Capabilities:
- Media and buffer preparation
- Cell expansion
- Cell culture production
- Harvest
- Capture and polish chromatography
- Viral inactivation, filtration, and QC testing
- Bulk storage, fill, and finish
- cGMP chemicals and supply chain services
- Expert professional support to meet process, scale, quality, and regulatory requirements
CONTACT INFORMATION
Thermo Fisher Scientific
7305 Executive Way
Frederick, MD 21704
UNITED STATES
Contact: Hunter Tuck
FEATURED SOLUTIONS
-
See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.
-
Highly sensitive detection of trace DNA impurities supports safer manufacturing. Combining rapid workflows, strong specificity, and reliable recovery from complex samples enables confident monitoring.
-
Accurate, high-sensitivity quantitation of residual host cell DNA becomes faster and more consistent with integrated qPCR, automated prep, and broad assay coverage—helping streamline workflows.
-
Closed, automated T cell isolation with greater than 85% efficiency and greater than 96% purity is now achievable in 70 to 100 minutes, with cGMP-ready scalability from research to clinical manufacturing.
-
Whole blood offers a faster, lower-cost starting material for T cell isolation and CTS Detachable Dynabeads CD4/CD8 with the DynaCellect System make it a viable, cGMP-aligned option without preprocessing.
-
Active bead release gives manufacturers precise control over T cell isolation timing, phenotype preservation, and workflow efficiency, eliminating multi-day passive dissociation delays.
-
Bead-free T cell activation is now achievable with a soluble, GMP-compliant format that supports up to 1.5 billion cells per vial, decouples activation from isolation, and removes with a simple cell wash.
-
Residual CD3+ cells shouldn't be the bottleneck in your allogeneic therapy workflow. This prototype achieves <0.5% residual T cells at commercial-scale processing capacity.
FEATURED INSIGHTS
-
Faster timelines don’t have to come at the expense of quality or consistency. Discover proven strategies to generate stable, high-performing cell lines while reducing risk and supporting reliable scale-up.
-
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
-
Uncertainty in media stability can limit efficiency and scalability in biologics manufacturing. See how a data-driven approach enables more predictable planning and reduces operational strain.
-
Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.
-
A CHO-S bispecific antibody program needed a better basal and feed media combination. Learn how the screening of 180 conditions in 12 weeks identified one that delivered 38% higher titers.
-
Amid a volatile pharma supply chain, strategic sourcing is now critical. Prioritizing your raw material supply ensures operational continuity, consistent performance, compliance, and on-time delivery.
-
Learn how closed-system automation, combined with expert technical guidance and protocol optimization, turned a persistent manufacturing bottleneck into a reliable, scalable process.
-
Lithium heparin reduces T cell purity to below 50% and spikes CD15+ contamination in whole blood workflows. See which anticoagulants consistently deliver above 90% CD3+ purity.